Navidea Biopharma (NAVB) Posts Narrower than Expected Q1 Loss
Navidea Biopharmaceuticals (AMEX: NAVB) reported Q1 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
